​

ADC Therapeutics (ADCT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

ADC Therapeutics Revenue Highlights

Latest Revenue (Y)

$73.55M

Latest Revenue (Q)

$15.75M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

ADC Therapeutics Revenue by Period

ADC Therapeutics Revenue by Year

DateRevenueChange
2025-12-31$73.55M3.83%
2024-12-31$70.84M1.84%
2023-12-31$69.56M-66.86%
2022-12-31$209.91M518.89%
2021-12-31$33.92M100.00%
2020-12-31--100.00%
2019-12-31$2.34M105.26%
2018-12-31$1.14M-36.77%
2017-12-31$1.80M-

ADC Therapeutics generated $73.55M in revenue during NA 2025, up 3.83% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

ADC Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30$15.75M-16.40%
2025-06-30$18.84M-18.21%
2025-03-31$23.03M36.21%
2024-12-31$16.91M-8.42%
2024-09-30$18.46M6.05%
2024-06-30$17.41M-3.56%
2024-03-31$18.05M7.52%
2023-12-31$16.79M15.85%
2023-09-30$14.49M-24.84%
2023-06-30$19.28M1.53%
2023-03-31$18.99M-72.79%
2022-12-31$69.80M-8.55%
2022-09-30$76.32M341.39%
2022-06-30$17.29M-62.81%
2022-03-31$46.50M173.36%
2021-12-31$17.01M29.38%
2021-09-30$13.15M249.65%
2021-06-30$3.76M100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30--100.00%
2019-06-30$1.96M67.69%
2019-03-31$1.17M354.37%
2018-12-31$257.50K-
2018-09-30$257.50K-17.60%
2018-06-30$312.50K-
2018-03-31$312.50K-

ADC Therapeutics generated $15.75M in revenue during Q3 2025, up -16.40% compared to the previous quarter, and up 90.47% compared to the same period a year ago.

ADC Therapeutics Revenue Breakdown

ADC Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22Dec 21
Product$73.55M$69.28M$69.06M--
Royalty Revenue$2.81M$1.56M$498.00K--
License Revenues$5.00M----
Contract Revenue---$135.00M-
Product Revenue---$74.91M$33.92M

ADC Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (90.41%), License Revenues (6.15%), and Royalty Revenue (3.45%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Jun 23Mar 23Sep 22Jun 22Mar 22
Royalty Revenue$746.00K$677.00K$754.00K$629.00K$904.00K$448.00K$205.00K$373.00K$86.00K$39.00K---
Product$22.31M$15.75M$18.09M$17.40M$33.42M$18.02M$17.85M------
License Revenues-$5.00M-----------
License Revenue----------$55.00M-$30.00M
Product Revenue, Net--------$19.20M$18.95M$21.32M$17.29M$16.50M

ADC Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product (96.76%), and Royalty Revenue (3.24%).

ADC Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 25Dec 24Dec 23
EMEA$7.81M$1.56M$498.00K
UNITED STATES$73.55M$69.28M$69.06M
JAPAN---

ADC Therapeutics's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (90.41%), and EMEA (9.59%).

Quarterly Revenue by Country

CountryDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Jun 23Mar 23
EMEA$746.00K$677.00K$754.00K$5.63M$904.00K$448.00K$205.00K$373.00K$86.00K$39.00K
UNITED STATES$22.31M$15.75M$18.09M$17.40M$33.42M$18.02M$17.85M$30.91M$19.20M$18.95M
JAPAN----------

ADC Therapeutics's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (96.76%), and EMEA (3.24%).

ADC Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ADCTADC Therapeutics$73.55M$15.75M
LXRXLexicon Pharmaceuticals$49.80M$14.18M
BCYCBicycle Therapeutics$35.27M$11.73M
AUTLAutolus Therapeutics$10.12M$21.14M
QSIQuantum-Si$2.44M$552.00K
ALMSAlumis-$2.67M
RAPTRAPT Therapeutics--
FDMT4D Molecular Therapeutics--
NMRANeumora Therapeutics--
OMEROmeros--

ADCT Revenue FAQ

What is ADC Therapeutics’s yearly revenue?

ADC Therapeutics's yearly revenue for 2025 was $73.55M, representing an increase of 3.83% compared to 2024. The company's yearly revenue for 2024 was $70.84M, representing an increase of 1.84% compared to 2023. ADCT's yearly revenue for 2023 was $69.56M, representing a decrease of -66.86% compared to 2022.

What is ADC Therapeutics’s quarterly revenue?

ADC Therapeutics's quarterly revenue for Q3 2025 was $15.75M, a -16.40% decrease from the previous quarter (Q2 2025), and a -14.70% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $18.84M, a -18.21% decrease from the previous quarter (Q1 2025), and a 8.21% increase year-over-year (Q2 2024). ADCT's quarterly revenue for Q1 2025 was $23.03M, a 36.21% increase from the previous quarter (Q4 2024), and a 27.59% increase year-over-year (Q1 2024).

What is ADC Therapeutics’s revenue growth rate?

ADC Therapeutics's revenue growth rate for the last 3 years (2023-2025) was 5.74%, and for the last 5 years (2021-2025) was 116.86%.

What are ADC Therapeutics’s revenue streams?

ADC Therapeutics's revenue streams in c 25 are Product, Royalty Revenue, and License Revenues. Product generated $73.55M in revenue, accounting 90.41% of the company's total revenue, up 6.16% year-over-year. Royalty Revenue generated $2.81M in revenue, accounting 3.45% of the company's total revenue, up 80.22% year-over-year. License Revenues generated $5M in revenue, accounting 6.15% of the company's total revenue

What is ADC Therapeutics’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of ADC Therapeutics was Product. This segment made a revenue of $73.55M, representing 90.41% of the company's total revenue.